News
Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic Institute of Organic Chemistry ...
The funds will support Phase 2 testing of a drug the company believes to be able to safety home in on AMPA receptors, an ...
Neurosteroids demonstrate significant therapeutic promise through the modulation of the GABA system and warrant further investigation.
aDepartments of Surgery, New York University, New York, NY, USA bDepartment of Medicine, New York University, New York, NY, USA ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the management of metabolic diseases, offering substantial benefits in glycemic control, weight reduction, cardiovascular ...
Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 6, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN ...
Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced ...
Further, PD + Cur was found to affect amino acid metabolism in the serum significantly. The B-type receptor for GABA (GABBR) agonist baclofen was further found to attenuate CTD-ILD-like lung injury ...
Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes. (HealthDay News) — For adults with diabetes and obesity ...
Glucagon-like peptide 1 (GLP-1) receptor agonists (RA) can reduce BMI which is a risk factor for intercranial hypertension (IIH). According to research published in the journal Eye, use of a GLP-1 RA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results